Loading ZYME…
SEC filing
ZYME · CIK 1937653
4 · Oct 9, 2026 · EVP, Head of R&D Schayowitz Adam sold 13.83K shares at $25.85/share ($357.6K); exercised options for 74.07K shares
EVP, Head of R&D Schayowitz Adam sold 13.83K shares at $25.85/share ($357.6K); exercised options for 74.07K shares
FORM 4